SINA [SINA] SC 13D/A: (Original Filing)
[]
SVA [SINOVAC BIOTECH] 6-K: (Original Filing)
[Sinovac Reports Unaudited Second Quarter 2012 Financial Results - Conference call scheduled for Wednesday, August 15, 2012 at 8:00 AM EDT - BEIJING, Aug. 15, 2012 /PRNewswire-Asia/ — Sinovac Biotech Ltd. (the company) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today its unaudited second quarter financial results for the period ended June 30, 2012. Sinovac is] []
SVA [SINOVAC BIOTECH] 6-K: Sinovac Reports Unaudited Second Quarter 2012 Financial Results
[Sinovac Reports Unaudited Second Quarter 2012 Financial Results - Conference call scheduled for Wednesday, August 15, 2012 at 8:00 AM EDT - BEIJING, Aug. 15, 2012 /PRNewswire-Asia/ — Sinovac Biotech Ltd. (the company) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today its unaudited second quarter financial results for the period ended June 30, 2012. Sinovac is] []
IMOS [CHIPMOS TECHNOLOGIES BERMUDA] 6-K: (Original Filing)
[Operating and Financial Review and Prospects This operating and financial review and prospects (FRP) discusses and analyzes the financial condition and results of ChipMOS TECHNOLOGIES (Bermuda) LTD, (also referred to as we, our, ChipMOS or the Company) for the six month period ended June 30, 2012. This should be read in conjunction with our unaudited condensed interim consolidated financial statements]
